Relapsing polychondritis occurring after esophageal cancer surgery: a case report with a literature review.
Junichi Mase, Yoshihiro Tanaka, Yuta Sato, Takeharu Imai, Naoki Okumura, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida
Author Information
Junichi Mase: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Yoshihiro Tanaka: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan. yoshihirotana11@hotmail.com. ORCID
Yuta Sato: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Takeharu Imai: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Naoki Okumura: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Nobuhisa Matsuhashi: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Takao Takahashi: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
Kazuhiro Yoshida: Department of Gastroenterological Surgery and Pediatric Surgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
INTRODUCTION: Relapsing polychondritis is a relatively rare chronic inflammatory disease of unknown etiology. In this case the treatment for esophageal cancer may have triggered relapsing polychondritis. CASE PRESENTATION: A 70-year-old man complained of dysphagia and weight loss. An upper gastrointestinal endoscopy revealed type 2 advanced esophageal cancer. A subtotal esophagectomy and three-region lymph node dissection were performed after chemotherapy. One month later, the patient developed respiratory distress accompanied by wheezing, dizziness, and hearing loss. The symptoms improved within a few days. The frequency of respiratory distress increased and the patient visited our department. Pharyngeal endoscopy revealed narrowing of the glottic space and a subglottic tumor. No malignant findings were found histopathologically on the biopsy specimens, but infiltration of inflammatory cells was observed. We diagnosed relapsing polychondritis based on the histopathological findings of the pharyngeal cartilage, in addition to the osteolytic changes of the cricoid cartilage on CT. The symptoms were relieved after the administration of oral steroids. Despite tapering of the steroids, no recurrence of relapsing polychondritis occurred. There was no evidence of esophageal cancer recurrence. CONCLUSION: Early diagnosis and treatment for relapsing polychondritis are necessary because this condition is often associated with airway lesions. Esophageal cancer treatment may trigger relapsing polychondritis.
Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med. 1960;263:51–8.
[DOI: 10.1056/NEJM196007142630201]
McAdam LP, O’Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine. 1976;55:193–215.
[DOI: 10.1097/00005792-197605000-00001]
Damiani JM, Levine HL. Relapsing polychondritis—report of ten cases. Laryngoscope. 1979;89:929–46.
[DOI: 10.1288/00005537-197906000-00009]
Ratnesh C, Nida C, Jonathan K. Relapsing polychondritis. Rheum Dis Clin N Am. 2013;39:263–76.
[DOI: 10.1016/j.rdc.2013.03.002]
Yanagi T, Matsumura T, Kamekura R, et al. Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic? Arch Dermatol. 2007;143:89–90.
[PMID: 17224547]
Tanaka Y, Yoshida K, Sanada Y, et al. Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study. Cancer Chemother Pharmacol. 2010;66:1159–65.
[DOI: 10.1007/s00280-010-1447-1]
Tanaka Y, Yoshida K, Yamada A, et al. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma. Cancer Chemother Pharmacol. 2016;77:1143–52.
[DOI: 10.1007/s00280-016-2985-y]
Jaksch-Wartenhorst R. Polychondropathia. Wein Arch Inn. 1923;6:93–100.
Glynn LE, Holborow EJ. Conversion of tissue polysaccharides to auto-antigens by Group-A beta-hemolytic streptococci. Lancet. 1952;2:449–51.
[DOI: 10.1016/S0140-6736(52)90242-0]
Kaye RL, Sones DA. Relapsing polychondritis—clinical and pathologic features in fourteen cases. Ann Intern Med. 1964;60:653–64.
[DOI: 10.7326/0003-4819-60-4-653]
Hilding AC. Syndrome of joint and cartilaginous pathologic changes with destructive iridocyclitis. Comparison with described concurrent eye and joint diseases. Arch Intern Med. 1952;89:445–53.
[DOI: 10.1001/archinte.1952.00240030094011]
Akiyama M. Relapsing polychondritis. Current encyclopedia of pathology—22A. Sensory organs. I. Equilibrium sensory organ. Tokyo: Nakayama Shoten; 1991.
Hermann JH, et al. Polychondritis. In: Kelley WN, et al., editors. Textbook of rheumatology. 3rd ed. Philadelphia: WB Saunders; 1989. p. 1513–22.
Shimizu Y, Okano K, Shihou T, et al. A case of relapsing polychondritis. J Nihon Univ Med Assoc. 1989;48:886–91.
Sunder S, Rath PC, Jairaj PS, et al. Relapsing polychondritis. A case report and review of literature. J Assoc Physicians India. 1989;37:285–7.
[PMID: 2693438]
Michet CJ Jr, McKenna CH, Luthra HS, et al. Relapsing polychondritis—survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74–8.
[DOI: 10.7326/0003-4819-104-1-74]
Spraggs PD, Tostevin PM, Howard DJ, et al. Management of laryngotracheobrochial sequelae and complications of relapsing polychondritis. Laryngoscope. 1997;107:936–41.
[DOI: 10.1097/00005537-199707000-00020]
Duke OL. Relapsing polychondritis. Br Med J. 1973;27:423–5.
Zeuner M, Straub RH, Rauh G, et al. Relapsing polychondritis. Clinical and immunogenetic analysis of 62 patients. J Rheumatol. 1997;24:96–101.
[PMID: 9002018]
Mohsenifar Z, Tashkin DP, Carson SA, et al. Pulmonary function in patients with relapsing polychondritis. Chest. 1982;81:711–7.
[DOI: 10.1378/chest.81.6.711]
Mori K, Ishioka K, Yamazaki H, et al. A case of the relapsing polychondritis limited to the trachea. J Otolaryngol Jpn. 2015;118:1150–4.
Oryoji D, Ono N, Himeji D, et al. A case of sudden respiratory failure due to tracheobronchomalacia by relapsing polychondritis, successfully rescued by multiple metallic stenting and tracheostomy. Intern Med. 2017;56:3369–72.
[DOI: 10.2169/internalmedicine.8778-16]
Letko E, Zafirakis P, Baltatzis S, et al. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum. 2002;31:384–95.
[DOI: 10.1053/sarh.2002.32586]
Hebbar M, Brouillard M, Wattel E, et al. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia. 1995;9:731–3.
[PMID: 7723411]
Fukuhara A, Oshima K, Tanino Y, et al. A suspected case of relapsing polychondritis manifesting after laryngeal cancer treatment. J Jpn Soc Respir. 2014;36:368–73.
